MEF2A and cardiac hypertrophy: Calcineurin is a key player in the development of cardiac hypertrophy [70] and it is able to activate two important transcriptional regulatory pathways, one through the nuclear factor of activated T cells (NFAT) and the other through the myocyte enhancer factor 2 (MEF2) [71,72].